After Settling with Applera, Genetic Technologies Considers Suing Other Potential Patent Infringers

While ABI and Celera are now in the clear, other research-tool and genetic-testing providers -- some 400 of them -- can expect to hear from Genetic Technologies, which has been emboldened by Applera s decision to settle rather than see the case play out in court. Subscribers: click headline for more

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.